News | Ultrasound Imaging | December 09, 2019

DiA Joins with IBM Watson Health to Arm Clinicians with its AI-powered Cardiac Ultrasound Software

DiA’s novel solution leverages AI to transform the way clinicians capture and analyze ultrasound images. By adding DiA to its AI Marketplace, IBM Watson Health will offer clinicians access to objective and accurate ultrasound analysis

DiA’s novel solution leverages AI to transform the way clinicians capture and analyze ultrasound images

December 9, 2019 —  DiA Imaging Analysis Ltd., an IBM Alpha Zone Accelerator Alumni Startup, announces a collaboration with IBM Watson Health, a leading provider of innovative AI, enterprise imaging, and interoperability solutions used by medical professionals worldwide. The IBM Imaging AI Marketplace will offer DiA’s FDA-cleared, AI-powered cardiac ultrasound software, designed to assist clinicians to analyze cardiac ultrasound images automatically.

Analyzing ultrasound images is often a visual process that can be challenging and highly dependent on user experience. DiA’s solutions address this challenge by assisting clinicians to objectively and accurately analyze ultrasound images, reducing the subjectivity associated with visual interpretation.

With the launch of the IBM Imaging AI Marketplace, IBM will be introducing DiA’s LVivo EF solution, one of several cardiology and general imaging AI solutions that the company has developed.  DiA’s LVivo EF application offers clinicians an AI-based quantification solution that will provide automated clinical data such as Ejection Fraction (EF) and Global Longitudinal Strain (GLS). The company anticipates adding additional solutions to the Marketplace in the near future.  

“IBM Watson Health is proud to announce a collaboration with DiA Imaging,” said Anne Le Grand, General Manager, Imaging, Life Sciences and Oncology, IBM Watson Health. “DiA’s innovative AI-powered offerings can provide our clients with the ability to analyze images with advanced AI-based solutions which can support IBM Watson Health’s mission to help build smarter health ecosystems.”

“Our collaboration with IBM Watson Health demonstrates the implementation of DiA’s vision to make the analysis of ultrasound images smarter and accessible to clinicians with various levels of experience, on any platform,” said Hila Goldman-Aslan, CEO and Co- Founder of DiA Imaging Analysis. “We are proud to offer our cross-platform, vendor-neutral solutions to healthcare providers in the IBM Watson Health’s ecosystem, leading the change to help transform ultrasound analysis with AI.”

DiA demonstrated its full suite of LVivo and additional solutions during the Radiological Society of North America’s (RSNA) 2019 annual meeting in Chicago. DiA’s AI was highlighted and demonstrated at the IBM Watson Health Booth.

For more information:

Related Content

Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the
Sponsored Content | Videos | Digital Radiography (DR) | January 06, 2020
An experienced technologist and two Agfa executives talk about what distinguishes the new Agfa 100s.
Sponsored Content | Videos | Ultrasound Imaging | January 06, 2020
The Arietta 850SE provides facilities with numerous features and functionality to get the most out of a system.
Sponsored Content | Videos | Computed Tomography (CT) | January 06, 2020
Hitachi announced the FDA clearance of its newest CT – Scenaria View – at RSNA2019.
Sponsored Content | Videos | Digital Radiography (DR) | January 03, 2020
At RSNA19, David Widmann, president and CEO of Konica Minolta Healthcare Americas, discussed innovation, stressing th
Videos | Advanced Visualization | December 30, 2019
This is a hologram of a fracture from a...